(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.75%.
Mediwound's earnings in 2026 is -$26,105,000.On average, 8 Wall Street analysts forecast MDWD's earnings for 2026 to be -$30,311,979, with the lowest MDWD earnings forecast at -$35,074,095, and the highest MDWD earnings forecast at -$27,170,708. On average, 8 Wall Street analysts forecast MDWD's earnings for 2027 to be -$27,948,301, with the lowest MDWD earnings forecast at -$32,929,276, and the highest MDWD earnings forecast at -$22,709,845.
In 2028, MDWD is forecast to generate -$14,926,187 in earnings, with the lowest earnings forecast at -$18,924,871 and the highest earnings forecast at -$12,571,522.